<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To obtain data on routine care of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> by French gastroenterologists </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS: Five thousand and forty-five adults with <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Patients were recruited by a representative sample of 598 French gastroenterologists </plain></SENT>
<SENT sid="3" pm="."><plain>A full disease history, with treatments given/investigations undertaken, was obtained from <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="4" pm="."><plain>The patients' expectations with regard to the improvement of the symptoms' control and the corresponding assessments made by the gastroenterologists were recorded on a 4-point scale </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The mean time since diagnosis was approximately 4 years </plain></SENT>
<SENT sid="6" pm="."><plain>The most commonly presented symptom was heartburn (79% of patients) </plain></SENT>
<SENT sid="7" pm="."><plain>A total of 3735 patients (74%) underwent endoscopy because of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0267055" disease_type="Disease or Syndrome" abbrv="">Erosive oesophagitis</z:e> was present in 38% and <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> in 8% </plain></SENT>
<SENT sid="9" pm="."><plain>Medical therapy for <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> was prescribed in 92% of patients, of whom 86% received <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>Lifestyle advice was given to 73% of patients </plain></SENT>
<SENT sid="11" pm="."><plain>Overall, 84% of patients and 72% of physicians expected 'highly' or 'moderately' improved control of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Gastroenterologists underrated the need for improvement of the symptoms' control as expressed by 'de novo' as well as 'previously diagnosed' patients </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: This study provides cross-sectional data on the management of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> by gastroenterologists in France </plain></SENT>
<SENT sid="14" pm="."><plain>Most patients have high expectations of an improvement in their management, but gastroenterologists generally underrate these expectations </plain></SENT>
</text></document>